ASCO GU 2018 Penile, Urethral, Testicular and Adrenal Cancers

Viewing 1-19 of 19 articles

ASCO GU 2018: Adrenal Cortical Carcinoma: Finding the Wolf in Sheep’s Clothing

ASCO GU 2018: Thromboembolic Complications in Germ Cell Tumor Patients: Should Use of Peripherally Inserted Central Catheters be Pursued?

ASCO GU 2018: Effect of Number of CT Scans During Follow-Up of Patients with Clinical Stage I Seminoma: A Trial-Level Meta-Analysis

ASCO GU 2018: Is Surveillance without Immediate Treatment an Option for Newly Diagnosed Testicular Germ-cell Cancer Patients with Borderline Size Retroperitoneal Lymph Nodes on CT Scan?

ASCO GU 2018: High-Dose Chemotherapy and Stem-Cell Rescue - Salvage Treatment for Germ Cell Testicular Tumors in Second- and Third-Line, and Outside Clinical Trials

ASCO GU 2018: Current Practice Patterns Surrounding Fertility Concerns in Stage I Seminoma Patients: Survey of United States Radiation Oncologists

ASCO GU 2018: Diagnostic Radiation and Testicular Germ Cell Tumor Risk

ASCO GU 2018: Surgical Management of Adrenocortical Carcinoma and Adrenal Tumors

ASCO GU 2018: Management of Marker Negative Stage IIA Testicular Cancer

ASCO GU 2018: Serum miRNA to Predict Post-chemotherapy Viable Disease in Testicular Non-seminomatous Germ Cell Tumor Patients

ASCO GU 2018: The Role of Imaging in Post-chemotherapy Masses in Germ Cell Tumors

ASCO GU 2018: Management of Metastatic Disease for Adrenocortical Carcinoma and Pheochromocytoma

ASCO GU 2018: Management of Adrenocortical Carcinoma and Pheochromocytoma Endocrinologic Issues

ASCO GU 2018: Impact of Medicaid Expansion on Diagnosis and Management of Patients with Testicular Cancer

ASCO GU 2018: Rapid Abstract: Long-term functioning in germ-cell tumor survivors.

ASCO GU 2018: Sentinel Node Biopsy in Clinical Stage I Testicular Cancer

ASCO GU 2018: Comparative Genomic Profiling of Refractory/Metastatic Penile And Non-penile Cutaneous Squamous Cell Carcinoma

ASCO GU 2018: VinCaP: A phase II trial of Vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis

ASCO GU 2018: Collateral damage: Molecular aging and p16INK4a senescence protein in testicular cancer survivors treated with chemotherapy